Description
Uses of Medicine:
Doxorubicin 50 mg injection, an anthracycline topoisomerase inhibitor is supplied generically under the brand Doxilyd. Patients, Healthcare Professionals, or Hospitals can buy Doxorubicin 50 mg injections online through THE INDIAN PHARMA (TIP) (a trusted Doxorubicin 50 mg injection Supplier, Exporter, and Contract Manufacturer in India). This therapeutic drug is used:- as part of multi-agent adjuvant chemotherapy to treat women who have axillary lymph node involvement after surgery for primary breast cancer. It helps reduce the risk of cancer returning by destroying any remaining cancer cells, improving survival chances after the tumor has been removed.
- for the treatment of: acute myeloblastic leukemia, acute lymphoblastic leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, metastatic breast cancer, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic Wilms’ tumor, metastatic bone sarcomas, metastatic transitional cell bladder carcinoma, metastatic ovarian carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, and metastatic bronchogenic carcinoma.
Do not take Doxorubicin 50 mg injection during pregnancy or breastfeeding, as it may be responsible for causing harm to the baby. Use effective birth control methods during treatment. This medicine may also temporarily affect fertility in men, so discuss it with your doctor in case you have concerns about having children in the future.
If you are on a low-salt diet, discuss it with your doctor because this injection contains sodium. Never stop taking this therapeutic drug without consulting your doctor first. Always follow your doctor’s advice to ensure safe and effective treatment.
Dosage & Side Effects:
Recommended Dosage for Adjuvant Breast Cancer:
The recommended dosage of Doxorubicin injection is 60 mg/m2 administered as an intravenous (IV) bolus on day 1 of each 21-day treatment cycle, along with cyclophosphamide, for a total of 4 cycles.Recommended Dosage for Other Cancers
: The recommended dosage of Doxorubicin for Injection when used as a single agent is 60 mg/m2 to 75 mg/m2 administered intravenously every 21 days. The dosage of Doxorubicin injection, when administered along with other chemotherapy drugs, is 40 mg/m2 to 75 mg/m2 administered intravenously every 21-28 days. Consider the use of the lower Doxorubicin dose in the recommended dose range or longer intervals between cycles for heavily pretreated patients, elderly patients, or obese patients. Cumulative doses beyond 550 mg/m2 are associated with an increased risk of cardiomyopathy.In case you miss a dose of Doxorubicin injection, inform your doctor immediately. Do not take a double dose to make up for the missed one. Your doctor will decide the best way to reschedule your treatment safely and effectively.
The most common side effects of Doxorubicin 50 mg injection are nausea, alopecia, and vomiting.